Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs
A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis
Evaluation of blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line antituberculous drugs